{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T03:39:28Z","timestamp":1789961968523,"version":"4.0.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T00:00:00Z","timestamp":1710720000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2021A1515111095"],"award-info":[{"award-number":["2021A1515111095"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203351"],"award-info":[{"award-number":["82203351"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.biopha.2024.116470","type":"journal-article","created":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T07:36:34Z","timestamp":1711956994000},"page":"116470","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["DMC-siERCC2 hybrid nanoparticle enhances TRAIL sensitivity by inducing cell cycle arrest for glioblastoma treatment"],"prefix":"10.1016","volume":"174","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1280-9662","authenticated-orcid":false,"given":"Meihui","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengfei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guifang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaishu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2024.116470_bib1","article-title":"Emerging therapies for glioblastoma: current state and future directions","volume":"41","author":"L","year":"2022","journal-title":"J. Exp. Clin. Cancer Res.: CR"},{"key":"10.1016\/j.biopha.2024.116470_bib2","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.3390\/cancers14102412","article-title":"Epidemiology of glioblastoma multiforme-literature review","volume":"14","author":"Grochans","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2024.116470_bib3","article-title":"The promise of DNA damage response inhibitors for the treatment of glioblastoma","volume":"3","author":"Majd","year":"2021","journal-title":"Neurooncol Adv."},{"key":"10.1016\/j.biopha.2024.116470_bib4","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s13402-021-00613-0","article-title":"DNA damage repair in glioblastoma: current perspectives on its role in tumour progression, treatment resistance and PIKKing potential therapeutic targets","volume":"44","author":"Lozinski","year":"2021","journal-title":"Cell Oncol. (Dordr. )"},{"key":"10.1016\/j.biopha.2024.116470_bib5","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1038\/srep04112","article-title":"Association of ERCC1 and ERCC2 polymorphisms with colorectal cancer risk in a Chinese population","volume":"4","author":"Ni","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2024.116470_bib6","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s41021-019-0119-6","article-title":"Mechanism and regulation of DNA damage recognition in nucleotide excision repair","volume":"41","author":"Kusakabe","year":"2019","journal-title":"Genes Environ."},{"key":"10.1016\/j.biopha.2024.116470_bib7","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nature01746","article-title":"Xpd\/Ercc2 regulates CAK activity and mitotic progression","volume":"424","author":"Chen","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2024.116470_bib8","doi-asserted-by":"crossref","first-page":"503","DOI":"10.4161\/cc.2.6.558","article-title":"Xpd, a structural bridge and a functional link","volume":"2","author":"Chen","year":"2003","journal-title":"Cell Cycle"},{"key":"10.1016\/j.biopha.2024.116470_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.dnarep.2020.102972","article-title":"Envisioning how the prototypic molecular machine TFIIH functions in transcription initiation and DNA repair","volume":"96","author":"Tsutakawa","year":"2020","journal-title":"DNA Repair (Amst. )"},{"key":"10.1016\/j.biopha.2024.116470_bib10","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.dnarep.2011.04.028","article-title":"XPB and XPD helicases in TFIIH orchestrate DNA duplex opening and damage verification to coordinate repair with transcription and cell cycle via CAK kinase","volume":"10","author":"Fuss","year":"2011","journal-title":"DNA Repair (Amst. )"},{"key":"10.1016\/j.biopha.2024.116470_bib11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.mad.2013.02.006","article-title":"Cockayne syndrome: the expanding clinical and mutational spectrum","volume":"134","author":"Laugel","year":"2013","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.biopha.2024.116470_bib12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejogrb.2016.11.012","article-title":"Association of R156R single nucleotide polymorphism of the ERCC2 gene with the susceptibility to ovarian cancer","volume":"208","author":"Romanowicz","year":"2017","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.biopha.2024.116470_bib13","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.7150\/jca.25356","article-title":"Polymorphisms in ERCC2 and ERCC5 and Risk of Prostate Cancer: A Meta-Analysis and Systematic Review","volume":"9","author":"Liu","year":"2018","journal-title":"J. Cancer"},{"key":"10.1016\/j.biopha.2024.116470_bib14","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1756-9966-28-104","article-title":"Statistically significant association of the single nucleotide polymorphism (SNP) rs13181 (ERCC2) with predisposition to Squamous Cell Carcinomas of the Head and Neck (SCCHN) and Breast cancer in the north Indian population","volume":"28","author":"Mitra","year":"2009","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.biopha.2024.116470_bib15","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.dnarep.2005.07.001","article-title":"Polymorphisms in the human XPD (ERCC2) gene, DNA repair capacity and cancer susceptibility: an appraisal","volume":"4","author":"Clarkson","year":"2005","journal-title":"DNA Repair (Amst. )"},{"key":"10.1016\/j.biopha.2024.116470_bib16","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3390\/biom11040572","article-title":"Overcoming TRAIL Resistance for Glioblastoma Treatment","volume":"11","author":"Deng","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.biopha.2024.116470_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1074-7613(02)00502-2","article-title":"Nature\u2019s TRAIL--on a path to cancer immunotherapy","volume":"18","author":"Smyth","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2024.116470_bib18","doi-asserted-by":"crossref","first-page":"5530","DOI":"10.1111\/febs.15637","article-title":"The multifaceted role of TRAIL signaling in cancer and immunity","volume":"288","author":"Cardoso Alves","year":"2021","journal-title":"FEBS J."},{"key":"10.1016\/j.biopha.2024.116470_bib19","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.trecan.2020.06.006","article-title":"TRAIL of Hope Meeting Resistance in Cancer","volume":"6","author":"Deng","year":"2020","journal-title":"Trends Cancer"},{"key":"10.1016\/j.biopha.2024.116470_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.179","article-title":"Cell cycle-arrested tumor cells exhibit increased sensitivity towards TRAIL-induced apoptosis","volume":"4","author":"Ehrhardt","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2024.116470_bib21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/374131a0","article-title":"Principles of CDK regulation","volume":"374","author":"Morgan","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2024.116470_bib22","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jconrel.2020.07.013","article-title":"TRAIL therapy and prospective developments for cancer treatment","volume":"326","author":"Thapa","year":"2020","journal-title":"J. Control Release"},{"key":"10.1016\/j.biopha.2024.116470_bib23","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.2147\/IJN.S189871","article-title":"Targeting EZH2 for glioma therapy with a novel nanoparticle-siRNA complex","volume":"14","author":"Wang","year":"2019","journal-title":"Int J. Nanomed."},{"key":"10.1016\/j.biopha.2024.116470_bib24","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s13311-017-0519-x","article-title":"Glioma Subclassifications and Their Clinical Significance","volume":"14","author":"Chen","year":"2017","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.biopha.2024.116470_bib25","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1074\/jbc.275.6.4258","article-title":"TFIIH with inactive XPD helicase functions in transcription initiation but is defective in DNA repair","volume":"275","author":"Winkler","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2024.116470_bib26","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41392-021-00648-7","article-title":"DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy","volume":"6","author":"Huang","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.biopha.2024.116470_bib27","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.180112","article-title":"Structural insights into the functional diversity of the CDK-cyclin family","volume":"8","author":"Wood","year":"2018","journal-title":"Open Biol."},{"key":"10.1016\/j.biopha.2024.116470_bib28","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41586-022-04698-x","article-title":"CDC7-independent G1\/S transition revealed by targeted protein degradation","volume":"605","author":"Suski","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2024.116470_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2022.166571","article-title":"IKBIP, a novel glioblastoma biomarker, maintains abnormal proliferation of tumor cells by inhibiting the ubiquitination and degradation of CDK4","volume":"1869","author":"Li","year":"2023","journal-title":"Biochim Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.biopha.2024.116470_bib30","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.ccell.2021.08.009","article-title":"Expanding control of the tumor cell cycle with a CDK2\/4\/6 inhibitor","volume":"39","author":"Freeman-Cook","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biopha.2024.116470_bib31","first-page":"1913","article-title":"CDK inhibitors in cancer therapy, an overview of recent development","volume":"11","author":"Zhang","year":"2021","journal-title":"Am. J. Cancer Res"},{"key":"10.1016\/j.biopha.2024.116470_bib32","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41568-022-00456-3","article-title":"Targeting CDK4 and CDK6 in cancer","volume":"22","author":"Goel","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2024.116470_bib33","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.00471","article-title":"RNA-programmed genome editing in human cells","volume":"2","author":"Jinek","year":"2013","journal-title":"Elife"},{"key":"10.1016\/j.biopha.2024.116470_bib34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2015.10.019","article-title":"Combo\u201d nanomedicine: Co-delivery of multi-modal therapeutics for efficient, targeted, and safe cancer therapy","volume":"98","author":"Kemp","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2024.116470_bib35","doi-asserted-by":"crossref","first-page":"18515","DOI":"10.1021\/acsami.8b03496","article-title":"A Universal GSH-Responsive Nanoplatform for the Delivery of DNA, mRNA, and Cas9\/sgRNA Ribonucleoprotein","volume":"10","author":"Chen","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biopha.2024.116470_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201902575","article-title":"Fast and efficient CRISPR\/Cas9 genome editing in vivo enabled by bioreducible lipid and messenger RNA nanoparticles","volume":"31","author":"Liu","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biopha.2024.116470_bib37","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/j.biomaterials.2010.10.044","article-title":"Polyethylenimine-grafted copolymer of poly(l-lysine) and poly(ethylene glycol) for gene delivery","volume":"32","author":"Dai","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2024.116470_bib38","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.bbrc.2015.06.137","article-title":"Effective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors including cancer stem cells: The promise of nanomedicine","volume":"468","author":"Kim","year":"2015","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.biopha.2024.116470_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1180943","article-title":"Advances in nanotechnology for the treatment of GBM","volume":"17","author":"Wei","year":"2023","journal-title":"Front Neurosci."},{"key":"10.1016\/j.biopha.2024.116470_bib40","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1080\/10717544.2016.1253798","article-title":"Successful delivery of docetaxel to rat brain using experimentally developed nanoliposome: a treatment strategy for brain tumor","volume":"24","author":"Shaw","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/j.biopha.2024.116470_bib41","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jconrel.2017.05.019","article-title":"Recent advancements in liposomes targeting strategies to cross blood-brain barrier (BBB) for the treatment of Alzheimer\u2019s disease","volume":"260","author":"Agrawal","year":"2017","journal-title":"J. Control Release"},{"key":"10.1016\/j.biopha.2024.116470_bib42","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1080\/09205063.2017.1348739","article-title":"Glioma targeted delivery strategy of doxorubicin-loaded liposomes by dual-ligand modification","volume":"28","author":"Han","year":"2017","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"10.1016\/j.biopha.2024.116470_bib43","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1166\/jbn.2016.2266","article-title":"Construction of functional targeting daunorubicin liposomes used for eliminating brain glioma and glioma stem cells","volume":"12","author":"Zhao","year":"2016","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.biopha.2024.116470_bib44","doi-asserted-by":"crossref","first-page":"8801","DOI":"10.1021\/acs.nanolett.2c01994","article-title":"Injectable immunotherapeutic hydrogel containing RNA-loaded lipid nanoparticles reshapes tumor microenvironment for pancreatic cancer therapy","volume":"22","author":"Gao","year":"2022","journal-title":"Nano Lett."},{"key":"10.1016\/j.biopha.2024.116470_bib45","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s10555-018-9728-y","article-title":"Developing TRAIL\/TRAIL death receptor-based cancer therapies","volume":"37","author":"Yuan","year":"2018","journal-title":"Cancer Metastas-.-. Rev."},{"key":"10.1016\/j.biopha.2024.116470_bib46","doi-asserted-by":"crossref","first-page":"5125","DOI":"10.3390\/cancers14205125","article-title":"TRAIL in the treatment of cancer: from soluble cytokine to nanosystems","volume":"14","author":"Alizadeh Zeinabad","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2024.116470_bib47","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s13205-022-03365-2","article-title":"Multifunctional nanocarriers for delivering siRNA and miRNA in glioblastoma therapy: advances in nanobiotechnology-based cancer therapy","volume":"12","author":"Shetty","year":"2022","journal-title":"3 Biotech"},{"key":"10.1016\/j.biopha.2024.116470_bib48","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2217\/nnm-2017-0230","article-title":"Nanoparticle\/siRNA-based therapy strategies in glioma: which nanoparticles, which siRNAs?","volume":"13","author":"Aigner","year":"2018","journal-title":"Nanomed. (Lond. )"},{"key":"10.1016\/j.biopha.2024.116470_bib49","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.7150\/thno.38147","article-title":"Nanocarrier-based drug combination therapy for glioblastoma","volume":"10","author":"Zhao","year":"2020","journal-title":"Theranostics"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224003548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224003548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T23:12:48Z","timestamp":1782342768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224003548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":49,"alternative-id":["S0753332224003548"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116470","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DMC-siERCC2 hybrid nanoparticle enhances TRAIL sensitivity by inducing cell cycle arrest for glioblastoma treatment","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116470","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116470"}}